The primary problem for AI creators isn't convincing people to trust their product, but stopping them from trusting it too much in areas where it's not yet reliable. This "low trustworthiness, high trust" scenario is a danger zone that can lead to catastrophic failures. The strategic challenge is managing and containing trust, not just building it.

For decades, keeping documentation updated was a low-priority task. Now, with AI support agents relying on this content as their source of truth, outdated information leads to immediate, tangible failures. This creates the urgent business case to finally solve knowledge decay.

To manage compliance risk in regulated industries, treat AI agents like new employees. Before deployment, the agent must pass the same knowledge assessment a human would take. This quantifies the risk, turning a 'black box' AI into an observable and testable system with a verifiable accuracy score.

AI provides vast amounts of data, but this accessibility leads to complacency. Over half of employees using AI make mistakes and fail to verify its output, which dulls their critical thinking and judgment abilities.

A key risk for AI in healthcare is its tendency to present information with unwarranted certainty, like an "overconfident intern who doesn't know what they don't know." To be safe, these systems must display "calibrated uncertainty," show their sources, and have clear accountability frameworks for when they are inevitably wrong.

Research shows cognitive, accuracy-based skills (like judging if an AI-generated draft is defensible) erode far more quickly than procedural skills (like running a workflow). This means teams lose their most critical risk-management capability—the ability to spot a plausible but incorrect AI output—first.

When junior employees are encouraged to use AI from day one, they fail to develop foundational skills. This "deskilling" means they won't be able to spot AI hallucinations or errors, ironically making them less competent and more liable, particularly in fields like law.

According to BCG research, leaders are beginning to worry less about immediate AI risks like hallucinations and more about the long-term, quiet erosion of critical thinking and judgment across the workforce. This "distributed de-skilling" undermines the very expertise needed to supervise AI effectively in the future.

A pharmaceutical manufacturer received an FDA warning letter not for using AI, but for failing to provide adequate human oversight. This signals that regulators are focused on the implementation and governance of AI systems, establishing a key compliance risk for the industry.